UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
P35610 (SOAT1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sterol O-acyltransferase 1; Acyl-coenzyme A:cholesterol acyltransferase 1; Cholesterol acyltransferase 1; | |
Q12834 (CDC20_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Cell division cycle protein 20 homolog; p55CDC; | |
Q9BW62 (KATL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Katanin p60 ATPase-containing subunit A-like 1; p60 katanin-like 1; | |
P78415 (IRX3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Iroquois-class homeodomain protein IRX-3; Homeodomain protein IRXB1; Iroquois homeobox protein 3; | |
P11230 (ACHB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Acetylcholine receptor subunit beta; | |
Q8TED4 (G6PT3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Glucose-6-phosphate exchanger SLC37A2; Solute carrier family 37 member 2; | |
Q6VVX0 (CP2R1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Vitamin D 25-hydroxylase; Cytochrome P450 2R1; | |
Q96QU6 (1A1L1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 1-aminocyclopropane-1-carboxylate synthase-like protein 1; | |
A8K5M9 (CO062_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein C15orf62, mitochondrial; | |
Q52LG2 (KR132_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Keratin-associated protein 13-2; | |
O60895 (RAMP2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Receptor activity-modifying protein 2; Calcitonin-receptor-like receptor activity-modifying protein 2; | |
P31152 (MK04_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Mitogen-activated protein kinase 4; Extracellular signal-regulated kinase 4; MAP kinase isoform p63; | |
Q96LI5 (CNO6L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CCR4-NOT transcription complex subunit 6-like; Carbon catabolite repressor protein 4 homolog B; | |
Q5T2N8 (ATD3C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ATPase family AAA domain-containing protein 3C; | |
P51168 (SCNNB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Epithelial sodium channel subunit beta; Amiloride-sensitive sodium channel subunit beta; Beta-NaCH; Nonvoltage-gated sodium channel 1 subunit beta; SCNEB; | |
Q92478 (CLC2B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | C-type lectin domain family 2 member B; Activation-induced C-type lectin; C-type lectin superfamily member 2; IFN-alpha-2b-inducing-related protein 1; | |
H0Y354 (FA72C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein FAM72C; | |
Q14236 (EPAG_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Early lymphoid activation gene protein; DIAPH2 antisense RNA 1; DIAPH2 antisense gene protein 1; | |
P16949 (STMN1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Stathmin; Leukemia-associated phosphoprotein p18; Metablastin; Oncoprotein 18; Phosphoprotein p19; Prosolin; Protein Pr22; pp17; | |
A0A286YF18 (SMI44_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Small integral membrane protein 44; | |
P59020 (DSCR9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Down syndrome critical region protein 9; | |
Q5R387 (PA2GC_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative inactive group IIC secretory phospholipase A2; Phosphatidylcholine 2-acylhydrolase-like protein GIIC; | |
Q6L9T8 (FA72D_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein FAM72D; Gastric cancer up-regulated protein 2; | |
Q96LM9 (CT173_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein C20orf173; | |
Q9NW61 (PKHJ1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Pleckstrin homology domain-containing family J member 1; Guanine nucleotide-releasing protein x; | |
Q9BXQ6 (T121B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transmembrane protein 121B; Cat eye syndrome critical region protein 6; | |
Q9GZN7 (ROGDI_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein rogdi homolog; | |
Q96BY2 (MOAP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Modulator of apoptosis 1; Paraneoplastic antigen Ma4; | |
Q9NYQ3 (HAOX2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 2-Hydroxyacid oxidase 2; (S)-2-hydroxy-acid oxidase, peroxisomal; Cell growth-inhibiting gene 16 protein; Long chain alpha-hydroxy acid oxidase; Long-chain L-2-hydroxy acid oxidase; | |
P49335 (PO3F4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | POU domain, class 3, transcription factor 4; Brain-specific homeobox/POU domain protein 4; Octamer-binding protein 9; Octamer-binding transcription factor 9; | |
A1KZ92 (PXDNL_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Probable oxidoreductase PXDNL; Cardiac peroxidase; Inactive peroxidasin-like protein; Polysomal ribonuclease 1; Vascular peroxidase 2; | |
Q9NQW6 (ANLN_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Anillin; | |
Q7Z412 (PEX26_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Peroxisome assembly protein 26; Peroxin-26; | |
Q9UJ71 (CLC4K_HUMAN) | Swiss-Prot | Homo sapiens (Human) | C-type lectin domain family 4 member K; Langerin; CD207; | |
Q8N9F0 (NAT8L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | N-acetylaspartate synthetase; Camello-like protein 3; N-acetyltransferase 8-like protein; | |
Q96HY7 (DHTK1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 2-oxoadipate dehydrogenase complex component E1; 2-oxoadipate dehydrogenase, mitochondrial; Alpha-ketoadipate dehydrogenase; Dehydrogenase E1 and transketolase domain-containing protein 1; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial; | |
Q58A44 (PCOTH_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Prostate collagen triple helix protein; C1QTNF9B antisense RNA 1; C1QTNF9B antisense gene protein 1; | |
P19876 (CXCL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | C-X-C motif chemokine 3; GRO-gamma(1-73); Growth-regulated protein gamma; Macrophage inflammatory protein 2-beta; GRO-gamma(5-73); | |
P0C7Q2 (ARMS2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Age-related maculopathy susceptibility protein 2; | |
P09341 (GROA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Growth-regulated alpha protein; C-X-C motif chemokine 1; GRO-alpha(1-73); Melanoma growth stimulatory activity; Neutrophil-activating protein 3; GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73); | |
P19875 (CXCL2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | C-X-C motif chemokine 2; Growth-regulated protein beta; Macrophage inflammatory protein 2-alpha; GRO-beta(5-73); GRO-beta-T; Hematopoietic synergistic factor; HSF; SB-251353; | |
Q96E16 (SMI19_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Small integral membrane protein 19; | |
Q9UJC5 (SH3L2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | SH3 domain-binding glutamic acid-rich-like protein 2; Fovea-associated SH3 domain-binding protein; | |
Q9NRX3 (NUA4L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2; NADH-ubiquinone oxidoreductase MLRQ subunit homolog; | |
Q9H4L5 (OSBL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Oxysterol-binding protein-related protein 3; | |
Q9UJY5 (GGA1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-binding protein GGA1; Gamma-adaptin-related protein 1; Golgi-localized, gamma ear-containing, ARF-binding protein 1; | |
Q96G46 (DUS3L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like; mRNA-dihydrouridine synthase DUS3L; tRNA-dihydrouridine synthase 3-like; | |
Q2VIR3 (IF2GL_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Eukaryotic translation initiation factor 2 subunit 3B; Eukaryotic translation initiation factor 2 subunit gamma A; | |
Q86VE0 (MYPOP_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Myb-related transcription factor, partner of profilin; Myb-related protein p42POP; Partner of profilin; | |
Q6NZ67 (MZT2B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Mitotic-spindle organizing protein 2B; Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2B; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_03 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
20,663 | 17,634 | 43,400 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 32-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 46-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
38,729 | 3,287 | 322 | 617 | 63 | 135 | 20 | 53 | 2 | 24 | 9 | 45 | 1 | 3 | 17 | 11 | 2 | 1 | 1 | 16 | 2 | 1 | 4 | 1 | 2 | 1 | 7 | 1 | 2 | 4 | 2 | 1 | 12 | 2 |